- Home
- COEP vs CXAI Comparison
COEP vs CXAI Comparison
Compare COEP & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COEP | CXAI |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | 7 | 41 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 9.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | COEP | CXAI |
|---|---|---|
| Price | $10.50 | $0.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 38.0K | ★ 10.6M |
| Earning Date | 03-19-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.21 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.32 | $0.16 |
| 52 Week High | $21.41 | $1.49 |
Technical Indicators
Market Signals| Indicator | COEP | CXAI |
|---|---|---|
| Relative Strength Index (RSI) | 37.72 | 45.28 |
| Support Level | $6.80 | $0.16 |
| Resistance Level | $13.23 | $0.25 |
| Average True Range (ATR) | 1.00 | 0.04 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 25.86 | 19.52 |
Price Performance
Historical ComparisonAbout COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.